EUVIMEDEUVIMED entdecken
Crossref

Polymer‐PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High‐Grade Serous Ovarian Cancer

He Zhang iD, Yi Sun, Lingpu Zhang, Meifang Shen, Xiaowei Tong, Dan Zhao, Haihua Xiao iD, Bin Li

Advanced Materials · 2026-01 · 38 (2)

DOI: 10.1002/adma.202512962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 19.09.2025. Verfasst von He Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences an…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Membrane Proteins, Poly(ADP-ribose) Polymerase Inhibitors, Polymers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Research Fund for Central Universities, Peking Union Medical College, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overcoming the immunosuppressive tumor microenvironment and therapeutic resistance remains a significant challenge in ovarian cancer treatment. In this study, a glutathione‐responsive polymeric nanoparticle platform for the co‐delivery of the USP1 inhibitor SJB3‐019A and the PARP inhibitor Niraparib is developed. This system synergistically enhances DNA damage accumulation, suppresses homologous recombination repair, and robustly activate the STING signaling pathway, leading to enhanced type I interferon responses and mitigation of immune evasion. Mechanistically, USP1 inhibition significantly impairs DNA repair, amplifying the synthetic lethality of PARP inhibition and promoting immunogenic cell death. In vivo studies demonstrated precise, glutathione‐responsive drug release and substantial tumor accumulation of the nanoparticles, resulting in remarkable antitumor efficacy in murine ovarian cancer models. Importantly, this combinational approach effectively remodels the tumor microenvironment by increasing CD8⁺ T cell infiltration and enhancing tumor sensitivity to immune checkpoint blockade therapies. This innovative strategy targeting DNA damage responses presents a promising platform for precise and effective ovarian cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsMembrane ProteinsPoly(ADP-ribose) Polymerase InhibitorsPolymersUbiquitin-Specific ProteasesFemaleAnimalsHumansMiceCell Line, TumorSignal TransductionNanoparticlesDNA DamagePhthalazinesTumor MicroenvironmentSynthetic Lethal MutationsGlutathioneIndazolesPiperidinesSTING Protein

Stichwörter der Autor:innen

STING pathwayhigh‐grade serous ovarian cancernanoparticle drug deliverytumor immune microenvironmenttumor immunotherapy

Substanzen

Membrane ProteinsPoly(ADP-ribose) Polymerase InhibitorsPolymersPhthalazinesUbiquitin-Specific ProteasesGlutathioneIndazolesPiperidinesSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of Gynecology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
  • College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.

ORCID-Profile: He Zhang, Haihua Xiao

Förderung

  • National Natural Science Foundation of China
  • Special Research Fund for Central Universities, Peking Union Medical College
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Zhang, H., Sun, Y., Zhang, L., Shen, M., Tong, X., Zhao, D., Xiao, H., & Li, B. (2026). Polymer‐PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High‐Grade Serous Ovarian Cancer. Advanced Materials, 38(2). https://doi.org/10.1002/adma.202512962

Vancouver

Zhang H, Sun Y, Zhang L, Shen M, Tong X, Zhao D, et al. Polymer‐PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High‐Grade Serous Ovarian Cancer. Advanced Materials. 2026;38(2). doi:10.1002/adma.202512962

BibTeX
@article{Zhang2026,
  author = {Zhang, He and Sun, Yi and Zhang, Lingpu and Shen, Meifang and Tong, Xiaowei and Zhao, Dan and Xiao, Haihua and Li, Bin},
  title = {Polymer‐PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High‐Grade Serous Ovarian Cancer},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {2},
  doi = {10.1002/adma.202512962}
}
Kostenlos starten →